On February 28, 2012, the Food and Drug Administration (FDA) approved crucial changes to the safety label for statins. The changes are based upon the FDA's further review of the data and are as follows:
News Stories
John O'Hurley fights high cholesterol.
Fox and Friends, FOX News - June 18, 2012
Name: Top Stories
A few weeks ago, FDA announced that cholesterol-lowering drugs known as statins would have to carry warnings that side effects can include, among other things, possible memory loss.
WebMD, April 2, 2012
Name: Top Stories